Pharmaceutical Technology11d
BMS-986484 by Bristol-Myers Squibb for Non-Small Cell Lung Cancer: Likelihood of Approval
BMS-986484 is under clinical development by Bristol-Myers Squibb and currently in Phase I for Non-Small Cell Lung Cancer.
Pharmaceutical Technology17d
BMS-813160 by Bristol-Myers Squibb for Pancreatic Ductal Adenocarcinoma: Likelihood of Approval
BMS-813160 is under clinical development by Bristol-Myers Squibb and currently in Phase II for Pancreatic Ductal Adenocarcinoma.